Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-14

Clinical Trial Update: Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial updating safety, efficacy, and acceptability of an eye drop formulation for dry eye disease; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eye drop formulation (unnamed in snippet)

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2013-03-14